Biotech S&P ETF, has not had a good 2 years and is far from its highs in 2021.....that being said it is close to a strong support line that was found in 2019, 2020 and 2022....so it is crucial that this level is held.
If support is found staying above $61, this can move higher to my Y target at $174 over the next few years.
A number of our members are keen on this sector and do a lot of good research on it and are quite bullish, I suspect they'll be buying while it is at its historic lows now.
Frederik Dalgaard
2023-11-15 13:54:08 +0000 UTC